Oscar van Loosbroek, Author at Treeway

Treeway announces first patient enrolled in the Phase 2a ASURE clinical trial exploring the safety and effectiveness of oral edaravone to delay disease progression in Alzheimer’s patients

Mar 6, 2023

Tilburg, March 6, 2023 – Treeway, in collaboration with the Alzheimer Drug Discovery Foundation (ADDF), announces today the successful enrollment of the first patient in the Alzheimer’s Disease Study Using Oral Edaravone (ASURE), Phase 2a clinical trial. The trial...

Spotlight: Miranda de Jager

Dec 7, 2021

Meet Miranda de Jager, Treeway’s CMC consultant. She joined the company in 2017 as a chemistry, manufacturing and controls consultant. Miranda de Jager joined with plenty of experience and immense motivation and commitment to the cause of developing treatment for...